Gérard Soula
Founder bij ADOCIA
Vermogen: 10 M $ op 31-03-2024
Actieve functies van Gérard Soula
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ADOCIA | Chairman | 24-02-2012 | - |
| Founder | 16-12-2005 | - | |
| Director/Board Member | 24-10-2011 | 24-02-2012 | |
| Chief Executive Officer | 16-12-2005 | 11-05-2023 | |
| President | 16-12-2005 | 11-05-2023 | |
GLOWBL SAS
 GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France. | Director/Board Member | - | - |
Loopbaan van Gérard Soula
Eerdere bekende functies van Gérard Soula
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Chairman | 01-08-1990 | 01-01-2005 |
| Chief Tech/Sci/R&D Officer | 01-08-1990 | 01-06-2005 | |
| Founder | 01-08-1990 | 01-01-2005 | |
| President | 01-08-1990 | 01-01-2005 | |
| Life Cycle Pharma A/S | Director/Board Member | - | - |
| VELOXIS PHARMACEUTICALS A/S | Director/Board Member | 01-11-2005 | - |
Opleiding van Gérard Soula
| Université d'Aix-Marseille | Doctorate Degree |
Statistieken
Internationaal
| Frankrijk | 5 |
| Denemarken | 3 |
Operationeel
| Director/Board Member | 4 |
| Chairman | 2 |
| Founder | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ADOCIA | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Life Cycle Pharma A/S | |
GLOWBL SAS
GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France. | Technology Services |
- Beurs
- Insiders
- Gérard Soula
- Ervaring
